Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-29

Clinical Trial Update: Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravenous ferric carboxymaltose to oral iron for iron-deficiency anemia in pregnant women has completed, evaluating efficacy and saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric carboxymaltose (ferric carboxymaltose)
  • Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Vifor Pharma | Conditions: Anaemia | Phase 3 | Status: COMPLETED